[go: up one dir, main page]

DK264785A - Galenisk retardpraeparat - Google Patents

Galenisk retardpraeparat Download PDF

Info

Publication number
DK264785A
DK264785A DK264785A DK264785A DK264785A DK 264785 A DK264785 A DK 264785A DK 264785 A DK264785 A DK 264785A DK 264785 A DK264785 A DK 264785A DK 264785 A DK264785 A DK 264785A
Authority
DK
Denmark
Prior art keywords
galenic
retard preparation
retard
preparation
galenic retard
Prior art date
Application number
DK264785A
Other languages
English (en)
Other versions
DK167649B1 (da
DK264785D0 (da
Inventor
Wolfgang Czarnecki
Jean Claude Gfeller
Hans Peter Bier
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of DK264785D0 publication Critical patent/DK264785D0/da
Publication of DK264785A publication Critical patent/DK264785A/da
Application granted granted Critical
Publication of DK167649B1 publication Critical patent/DK167649B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK264785A 1984-06-14 1985-06-12 Fast laegemiddeldispersion med forlaenget afgivelse, sekundaer struktur af laegemidlet samt farmaceutisk praeparat indeholdende dispersionen eller strukturen DK167649B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE3422083 1984-06-14
DE3422083 1984-06-14
DE3442566 1984-11-22
DE3442566 1984-11-22

Publications (3)

Publication Number Publication Date
DK264785D0 DK264785D0 (da) 1985-06-12
DK264785A true DK264785A (da) 1985-12-15
DK167649B1 DK167649B1 (da) 1993-12-06

Family

ID=25822108

Family Applications (1)

Application Number Title Priority Date Filing Date
DK264785A DK167649B1 (da) 1984-06-14 1985-06-12 Fast laegemiddeldispersion med forlaenget afgivelse, sekundaer struktur af laegemidlet samt farmaceutisk praeparat indeholdende dispersionen eller strukturen

Country Status (21)

Country Link
AT (1) AT391806B (da)
AU (2) AU587190B2 (da)
BE (1) BE902626A (da)
CA (1) CA1264441A (da)
CY (1) CY1635A (da)
DE (1) DE3520184C2 (da)
DK (1) DK167649B1 (da)
ES (1) ES8702141A1 (da)
FR (1) FR2565822B1 (da)
GB (3) GB2160100B (da)
GR (1) GR851430B (da)
HK (1) HK25192A (da)
HU (1) HU198844B (da)
IE (1) IE58834B1 (da)
IL (1) IL75490A0 (da)
IT (1) IT1200080B (da)
LU (1) LU85946A1 (da)
NL (1) NL194389C (da)
NZ (1) NZ212390A (da)
PT (1) PT80635B (da)
SE (1) SE504583C2 (da)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1187751B (it) * 1985-10-15 1987-12-23 Eurand Spa Procedimento per la preparazione di formulazioni solidi di nifedipina ad elevata biodisponibilita' e ad effetto prolungato e formulazioni cosi' ottenute
US4816263A (en) * 1987-10-02 1989-03-28 Alza Corporation Dosage form for treating cardiovascular diseases comprising isradipine
WO1989009066A1 (en) * 1988-03-24 1989-10-05 Bukh Meditec A/S Controlled release composition
GR1000270B (el) * 1988-09-30 1992-05-12 Alza Corp Μορφη δοσολογιας για θεραπεια καρδιαγγειακων ασθενειων.
DK469989D0 (da) * 1989-09-22 1989-09-22 Bukh Meditec Farmaceutisk praeparat
MX9300110A (es) * 1992-01-13 1994-07-29 Gerhard Gergely Preparacion farmaceutica en la forma de una tableta de efervescencia o de desintegracion o de un granulado de tipo instanteneo y procedimiento para su preparacion.
DE4201179A1 (de) * 1992-01-17 1993-07-22 Alfatec Pharma Gmbh Wirkstoff(e) enthaltendes granulat oder pellet mit einem geruest aus hydrophilen makromolekuelen und verfahren zu seiner herstellung
US5773025A (en) * 1993-09-09 1998-06-30 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems--amorphous drugs
US6726930B1 (en) 1993-09-09 2004-04-27 Penwest Pharmaceuticals Co. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5455046A (en) * 1993-09-09 1995-10-03 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems for insoluble drugs
GB2281697A (en) * 1993-09-14 1995-03-15 Euro Celtique Sa Laxative compositions in capsules
JP3148256B2 (ja) 1996-07-08 2001-03-19 エドワード メンデル カンパニー．，インコーポレーテッド 高用量難溶性薬物用持続放出マトリックス
DE19710009A1 (de) * 1997-03-12 1998-09-24 Knoll Ag Mehrphasige wirkstoffhaltige Zubereitungsformen
US6056977A (en) 1997-10-15 2000-05-02 Edward Mendell Co., Inc. Once-a-day controlled release sulfonylurea formulation
US6787157B1 (en) 1998-03-10 2004-09-07 Abbott Laboratories Multiphase active ingredient-containing formulations
US7001892B1 (en) 1999-06-11 2006-02-21 Purdue Research Foundation Pharmaceutical materials and methods for their preparation and use
EP1189599A2 (en) * 1999-06-11 2002-03-27 Eli Lilly And Company Pharmaceutical materials and methods for their preparation and use
WO2001010466A1 (fr) * 1999-08-04 2001-02-15 Yamanouchi Pharmaceutical Co., Ltd. Compositions medicinales stables pour administration orale
CA2352211C (en) 1999-09-30 2009-03-24 Edward Mendell Co., Inc. Sustained release matrix systems for highly soluble drugs
JP2004518709A (ja) * 2001-02-13 2004-06-24 アストラゼネカ・アクチエボラーグ 新規放出修飾製剤
US7135436B2 (en) 2003-05-05 2006-11-14 J.F. Daley International, Ltd. Solid algicide, preparation and usage in recirculating water
EP1690528A1 (de) 2005-02-11 2006-08-16 Abbott GmbH & Co. KG Herstellung von Dosierungsformen mit einer festen Dispersion eines mikrokristallinen Wirkstoffs
US20100210792A1 (en) 2006-12-05 2010-08-19 David Taft Drug delivery
US8399007B2 (en) 2006-12-05 2013-03-19 Landec Corporation Method for formulating a controlled-release pharmaceutical formulation
US8114883B2 (en) 2007-12-04 2012-02-14 Landec Corporation Polymer formulations for delivery of bioactive materials
US9192578B2 (en) * 2008-08-20 2015-11-24 Board Of Regents, The University Of Texas System Hot-melt extrusion of modified release multi-particulates

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1617362A1 (de) * 1967-11-17 1971-03-25 Beiersdorf Ag Verfahren zur Herstellung von Arzneimitteln mit verzoegerter Wirkstoffabgabe in Form von Kapseln
DE2400819C2 (de) * 1974-01-09 1982-04-22 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung fester Zubereitungen von schwerlöslichen Arzneimittelwirkstoffen in feinster Verteilung
DE2546577B2 (de) * 1975-10-17 1981-04-02 Sandoz-Patent-GmbH, 7850 Lörrach Feste Stoffe aus Polyvinylpyrrolidon und Ergotalkaloiden
GB1504553A (en) * 1975-11-17 1978-03-22 Sandoz Ltd Tablet formulations
GB1579818A (en) * 1977-06-07 1980-11-26 Yamanouchi Pharma Co Ltd Nifedipine-containing solid preparation composition
CH639659A5 (de) * 1978-12-18 1983-11-30 Sandoz Ag Neue 1,4-dihydropyridinderivate, deren herstellung und verwendung.
FI64938C (fi) * 1977-06-20 1984-02-10 Sandoz Ag Foerfarande foer framstaellning av nya terapeutiskt anvaendbara bensoxa- och bensotiadiazolyl-1,4-dihydropyridinderivat
EP0001247A1 (en) * 1977-09-14 1979-04-04 Kanebo, Ltd. Pharmaceutical preparation containing nifedipine and a method for producing the same.
CH642259A5 (de) * 1978-12-21 1984-04-13 Sandoz Ag Galenische zubereitungen fuer orale applikation von ergotalkaloiden.
DE2904310A1 (de) * 1979-02-05 1980-08-07 Boehringer Mannheim Gmbh Formlinge mit retardierter wirkstofffreisetzung und verfahren zu deren herstellung
JPS56115726A (en) * 1980-02-20 1981-09-11 Kaken Pharmaceut Co Ltd Pharmaceutical containing nifedipine
DE3033919A1 (de) * 1980-09-09 1982-04-22 Bayer Ag, 5090 Leverkusen Feste arzneizubereitungen enthaltend nifedipin und verfahren zu ihrer herstellung
US4442112A (en) * 1981-09-02 1984-04-10 Sandoz Ltd. Dihydropyridine derivatives useful in treating vascular headaches
DE3270785D1 (en) * 1981-10-29 1986-05-28 Bayer Ag Process for preparing solid fast-releasing drug formulations of dihydropyridines
CA1208558A (en) * 1982-10-07 1986-07-29 Kazuo Kigasawa Soft buccal
DE3318649A1 (de) * 1983-05-21 1984-11-22 Bayer Ag, 5090 Leverkusen Zweiphasenformulierung

Also Published As

Publication number Publication date
GB2196851B (en) 1989-06-07
ES8702141A1 (es) 1987-01-01
NL194389C (nl) 2002-03-04
CA1264441A (en) 1990-01-16
NL194389B (nl) 2001-11-01
AU587190B2 (en) 1989-08-10
FR2565822A1 (fr) 1985-12-20
AU4348685A (en) 1985-12-19
LU85946A1 (fr) 1986-01-24
GB2160100B (en) 1989-06-01
PT80635A (en) 1985-07-01
GB2196851A (en) 1988-05-11
ATA174885A (de) 1990-06-15
PT80635B (pt) 1987-10-20
CY1635A (en) 1992-11-06
IE851460L (en) 1985-12-14
HK25192A (en) 1992-04-10
SE504583C2 (sv) 1997-03-10
AU4454389A (en) 1990-03-22
IL75490A0 (en) 1985-10-31
GB8514855D0 (en) 1985-07-17
ES544075A0 (es) 1987-01-01
GB8727056D0 (en) 1987-12-23
NZ212390A (en) 1992-02-25
DK167649B1 (da) 1993-12-06
HU198844B (en) 1989-12-28
GB2160100A (en) 1985-12-18
DK264785D0 (da) 1985-06-12
GB2196852B (en) 1989-05-17
NL8501578A (nl) 1986-01-02
SE8502950D0 (sv) 1985-06-13
SE8502950L (sv) 1985-12-15
DE3520184A1 (de) 1985-12-19
BE902626A (fr) 1985-12-10
IT8548210A0 (it) 1985-06-13
DE3520184C2 (de) 1997-03-13
GB8727055D0 (en) 1987-12-23
AT391806B (de) 1990-12-10
IE58834B1 (en) 1993-11-17
IT1200080B (it) 1989-01-05
GR851430B (da) 1985-11-25
FR2565822B1 (fr) 1989-02-17
GB2196852A (en) 1988-05-11
HUT40918A (en) 1987-03-30

Similar Documents

Publication Publication Date Title
DK264785D0 (da) Galenisk retardpraeparat
DK60885D0 (da) Oralt praeparat
DK268285A (da) Dialkoxypyridinderivater
DK35785D0 (da) Tetrahydrocarbazolonderivater
DK243985D0 (da) Aminoalkylphenoxyderivater
DE3463503D1 (de) Sulfonamido-benzamide derivatives
DE3566887D1 (de) Flavanon derivatives
DK501085A (da) Substituerede benzimidazolderivater
DK524585D0 (da) Cholecalciferolderivater
DK460785A (da) Substituerede furanylderivater
DK443685D0 (da) Pirimidinderivater
DK320585D0 (da) Fluorallylaminderivater
DK333785A (da) Mevalonolactonderivater
DK201785A (da) Topisk farmaceutisk praeparat
DE3588103D1 (de) 5-Fluorouracil-Derivate
FI840579A0 (fi) Pipett med reglerbar volym
DK514585A (da) Aminoethylanilinderivater
DE3565100D1 (de) Cycloalkane-indene-carboximidamide derivatives
DK267190D0 (da) 13-substitueret-5-ketomilbemycinderivater
DK54085D0 (da) Phenylpropargylaminderivater
DE3564269D1 (de) Eburnane derivatives
ZA854520B (en) Novel galenic retard form
ES542485A0 (es) Procedimiento de preparacion de derivados de bornano
SE8404468D0 (sv) Farmaceutisk beredning
ATE46263T1 (de) Theophyllin-retardzubereitung.

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired